241 related articles for article (PubMed ID: 28603203)
1. [Neonatal lupus erythematosus].
Yokogawa N; Sumitomo N; Miura M; Shibuya K; Nagai H; Goto M; Murashima A
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):124-130. PubMed ID: 28603203
[TBL] [Abstract][Full Text] [Related]
2. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus.
Izmirly PM; Costedoat-Chalumeau N; Pisoni CN; Khamashta MA; Kim MY; Saxena A; Friedman D; Llanos C; Piette JC; Buyon JP
Circulation; 2012 Jul; 126(1):76-82. PubMed ID: 22626746
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine.
Izmirly PM; Kim MY; Llanos C; Le PU; Guerra MM; Askanase AD; Salmon JE; Buyon JP
Ann Rheum Dis; 2010 Oct; 69(10):1827-30. PubMed ID: 20447951
[TBL] [Abstract][Full Text] [Related]
4. Neonatal lupus erythematosus: a 20-year retrospective study.
Singalavanija S; Limpongsanurak W; Aoongern S
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S74-82. PubMed ID: 25391176
[TBL] [Abstract][Full Text] [Related]
5. Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.
Llanos C; Izmirly PM; Katholi M; Clancy RM; Friedman DM; Kim MY; Buyon JP
Arthritis Rheum; 2009 Oct; 60(10):3091-7. PubMed ID: 19790064
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block.
Izmirly PM; Llanos C; Lee LA; Askanase A; Kim MY; Buyon JP
Arthritis Rheum; 2010 Apr; 62(4):1153-7. PubMed ID: 20131261
[TBL] [Abstract][Full Text] [Related]
7. A case of severe neonatal lupus erythematosus without cardiac or cutaneous involvement.
Selander B; Cedergren S; Domanski H
Acta Paediatr; 1998 Jan; 87(1):105-7. PubMed ID: 9510460
[TBL] [Abstract][Full Text] [Related]
8. Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus.
Rivera TL; Izmirly PM; Birnbaum BK; Byrne P; Brauth JB; Katholi M; Kim MY; Fischer J; Clancy RM; Buyon JP
Ann Rheum Dis; 2009 Jun; 68(6):828-35. PubMed ID: 18625627
[TBL] [Abstract][Full Text] [Related]
9. Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.
Saxena A; Izmirly PM; Han SW; Briassouli P; Rivera TL; Zhong H; Friedman DM; Clancy RM; Buyon JP
J Am Coll Cardiol; 2015 Aug; 66(8):930-9. PubMed ID: 26293764
[TBL] [Abstract][Full Text] [Related]
10. Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus.
Reed JH; Clancy RM; Lee KH; Saxena A; Izmirly PM; Buyon JP
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1373-81. PubMed ID: 22511615
[TBL] [Abstract][Full Text] [Related]
11. [Neonatal lupus syndrome: Literature review].
Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N
Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481
[TBL] [Abstract][Full Text] [Related]
12. [Neonatal cutaneous lupus. Necessary interdisciplinary collaboration].
Stirnemann J; Fain O; Lachassinne E; Levet R; Carbillon L; Kettaneh A; Aurousseau MH; Uzan M; Thomas M
Presse Med; 2002 Sep; 31(30):1407-9. PubMed ID: 12378974
[TBL] [Abstract][Full Text] [Related]
13. Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus.
Barsalou J; Costedoat-Chalumeau N; Berhanu A; Fors-Nieves C; Shah U; Brown P; Laskin CA; Morel N; Levesque K; Buyon JP; Silverman ED; Izmirly PM
Ann Rheum Dis; 2018 Dec; 77(12):1742-1749. PubMed ID: 30297329
[TBL] [Abstract][Full Text] [Related]
14. [Neonatal lupus erythematosus: a report of 7 cases and review of 87 cases of China].
Li L; Dong GF; Han FZ; Cui Y; Shi YZ; Zhang X
Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):146-50. PubMed ID: 21426696
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry.
Neiman AR; Lee LA; Weston WL; Buyon JP
J Pediatr; 2000 Nov; 137(5):674-80. PubMed ID: 11060534
[TBL] [Abstract][Full Text] [Related]
16. Neonatal lupus erythematosus: clinical character, investigation, and outcome.
Wisuthsarewong W; Soongswang J; Chantorn R
Pediatr Dermatol; 2011; 28(2):115-21. PubMed ID: 21362029
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of neonatal lupus erythematosus.
Liu J; Yang YH; Lin YT; Chiang BL
J Microbiol Immunol Infect; 2001 Dec; 34(4):265-8. PubMed ID: 11825006
[TBL] [Abstract][Full Text] [Related]
18. Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature.
Zuppa AA; Riccardi R; Frezza S; Gallini F; Luciano RM; Alighieri G; Romagnoli C; De Carolis S
Autoimmun Rev; 2017 Apr; 16(4):427-432. PubMed ID: 28212920
[TBL] [Abstract][Full Text] [Related]
19. Neonatal lupus erythematosus in Japan: a review of the literature.
Kobayashi R; Mii S; Nakano T; Harada H; Eto H
Autoimmun Rev; 2009 May; 8(6):462-6. PubMed ID: 19162245
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome of 126 anti-SSA/Ro-positive patients during the past 24 years--a retrospective cohort study.
Luo Y; Zhang L; Fei Y; Li Y; Hao D; Liu Y; Zhao Y
Clin Rheumatol; 2015 Oct; 34(10):1721-8. PubMed ID: 26384980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
